Publication | Closed Access

A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion

Regenerative MedicineBone Morphogenic ProteinMedicineStem Cell ResearchMesenchymal Stem CellStem Cell TraffickingRadiation OncologyStem CellsCell BiologyTumor BiologyNovel AntagonistCxcr4 PreventsHealth Sciences